Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...

Driving the Next Era of AI-Powered Market Intelligence As Senior Vice President of Sales, Davis will lead Crunchbase’s global sales strategy, focusing on: Strengthening customer relationships by ...

Parnassus Growth Equity Fund stated the following regarding Exact Sciences Corporation (NASDAQ:EXAS) in its Q4 2024 investor letter: “We bought two new positions in biotechnology company Vertex ...

Davis joins Crunchbase from Google Cloud, where she served as Head of Sales, Data Analytics, leading enterprise sales teams across the Mid-Atlantic ... Big Query and Vertex, driving significant ...

The FDA is due to make an approval decision on injectable Keytruda by mid-September. The move could bolster downtrodden Merck stock.

We tried Shark's vast vacuum lineup and explored the effectiveness of features like lift-away pods, dirt detection, and ...

I'm Dan Maller, Head of Investor Relations at BeiGene ... which is akin to that of Gilead and HIV and Vertex in cystic fibrosis. Our focus for 2025 is to deliver upon three strategic pillars ...

Stoke Therapeutics, Inc. is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine and has a lead investigational medicine, zorevunersen ...

After hitting a record high in 2021, the number of biotech IPOs have fallen to a yearly average in the 20s, with most successful entries in the last few quarters involving companies with mid- to ...

The closest – less than 50km away – is Wiluna, which continues to operate despite the collapse of owner Wiluna Mining Corporation in mid-2022. WGR believes it ... Over in New South Wales, Vertex ...